Gui Zhao

IMM47, a humanized monoclonal antibody that targets CD24, exhibits exceptional anti-tumor efficacy by blocking the CD24/Siglec-10 interaction and can be used as monotherapy or in combination with anti-PD1 antibodies for cancer immunotherapy

Song Li, Dianze Chen, Huiqin Guo et al. · Antibody Therapeutics · 2023 · 19 citations · Full text

Life Sciences, Immunology, Oncology +17

Leveraging T cell-specific fusogenicity of HIV for in vivo mRNA delivery to produce human CAR-T cells

Yue Wang, Min Yang, Bao-Yue Zhang et al. · Cell Biomaterials · 2025 · 17 citations · Full text

Pharmacy, Immunology, Infectious Diseases +14

Crystal Structure of Human CD47 in Complex with Engineered SIRPα.D1(N80A)

Jifeng Yu, Song Li, Dianze Chen et al. · Molecules · 2022 · 16 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

The novel high-affinity humanized antibody IMM40H targets CD70, eliminates tumors via Fc-mediated effector functions, and interrupts CD70/CD27 signaling

Song Li, Dianze Chen, Huiqin Guo et al. · Frontiers in Oncology · 2023 · 10 citations · Full text

Life Sciences, Immunology, Oncology +16